Skip Navigation
Skip to contents

PHRP : Osong Public Health and Research Perspectives

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
7 "Young-Joon Park"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
Analysis of pregnant women with critically severe COVID-19 in Republic of Korea from February 2020 and December 2021
Ji Joo Lee, Sang-Eun Lee, Yeonjung Kim, Young-Joon Park
Osong Public Health Res Perspect. 2023;14(2):129-137.   Published online April 5, 2023
DOI: https://doi.org/10.24171/j.phrp.2023.0025
  • 387 View
  • 30 Download
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Objectives
This study aimed to describe the characteristics and risk factors for severe disease in pregnant women infected with coronavirus disease 2019 (COVID-19) from the early days of the COVID-19 epidemic in Korea to the predominant period of the Delta variant.
Methods
A retrospective cohort study was conducted among pregnant women diagnosed with COVID-19 between February 2020 and December 2021. Logistic regression analysis was performed to compare severe and mild cases after adjusting for pregnant women’s age, nationality, infection route, outbreak area, infection period, symptoms, underlying disease, smoking status, trimester, and COVID-19 vaccination status.
Results
In total, 2,233 pregnant women were diagnosed with COVID-19 by December 2021. Among these, 96.7% had mild symptoms, 3.3% had severe symptoms, and 0.04% died. The risk factors for severe disease in pregnant women with confirmed COVID-19 were being in the age group of 35 to 45 years, having hyperlipidemia, being in the second or third trimester of pregnancy at the time of COVID-19 diagnosis, being infected during the Delta-predominant period, and having a fever (≥38 °C) at diagnosis. Furthermore, 47.1% of patients in the mild group and 84.9% of patients in the severe group had 3 or more risk factors.
Conclusion
Pregnant women with COVID-19 mainly experienced mild symptoms, but those with risk factors were at a higher risk of developing severe symptoms. Therefore, treatment and follow-up management should be thoroughly implemented.
Brief Report
Presumed population immunity to SARS-CoV-2 in South Korea, April 2022
Eun Jung Jang, Young June Choe, Seung Ah Choe, Yoo-Yeon Kim, Ryu Kyung Kim, Jia Kim, Do Sang Lim, Ju Hee Lee, Seonju Yi, Sangwon Lee, Young-Joon Park
Osong Public Health Res Perspect. 2022;13(5):377-381.   Published online October 14, 2022
DOI: https://doi.org/10.24171/j.phrp.2022.0209
  • 1,467 View
  • 61 Download
  • 1 Citations
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Objectives
We estimated the overall and age-specific percentages of the Korean population with presumed immunity against severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) as of April 2022 using the national registry.
Methods
We used the national coronavirus disease 2019 (COVID-19) infection and vaccination registry from South Korea, as described to define individuals with a previous history of COVID-19 infection, vaccination, or both, as persons with presumed immunity.
Results
Of a total of 53,304,627 observed persons, 24.4% had vaccination and infection, 58.1% had vaccination and no infection, 7.6% had infection and no vaccination, and 9.9% had no immunity. The SARS-CoV-2 Omicron variant emerged at a time when the presumed population immunity ranged from 80% to 85%; however, nearly half of the children were presumed to have no immunity.
Conclusion
We report a gap in population immunity, with lower presumed protection in children than in adults. The approach presented in this work can provide valuable informed tools to assist vaccine policy-making at a national level.

Citations

Citations to this article as recorded by  
  • Predicting adherence to COVID-19 preventive measures among South Korean adults aged 40 to 69 Years using the expanded health empowerment model
    Su-Jung Nam, Tae-Young Pak
    SSM - Population Health.2023; 22: 101411.     CrossRef
Original Article
Characteristics of COVID-19 outbreaks and risk factors for transmission at an army training center in South Korea from June to August 2021
U Jin Cho, Seongjin Wang, Seonju Yi, Yeon Hwa Choi, Eun-Young Kim, Jin A Kim, Sanghwan Bae, Jungyeon Yu, Jangkyu Choi, Young-Joon Park
Osong Public Health Res Perspect. 2022;13(4):263-272.   Published online July 27, 2022
DOI: https://doi.org/10.24171/j.phrp.2022.0149
  • 1,562 View
  • 100 Download
  • 1 Citations
AbstractAbstract PDF
Objectives
It is crucial to establish the characteristics of coronavirus disease 2019 (COVID-19) outbreaks at army training centers to develop preventive measures. Therefore, this study aimed to determine the COVID-19 transmission patterns and risk factors in a sequence of outbreaks at an army training center from June to August 2021.
Methods
This study included 1,324 trainees at an army training center where outbreaks occurred from June to August 2021. The outbreak was qualitatively analyzed according to the period, attack rate, demographic characteristics, vaccination history, and living areas. An aerodynamic experiment was performed to evaluate aerosol transmission in living areas.
Results
Three outbreaks occurred at the army training center from June to August 2021. The first, second, and third outbreaks lasted for 32, 17, and 24 days, and the attack rates were 12.8%, 18.1%, and 8.9%, respectively. Confirmed cases were distributed in all age groups. Recruits and the unvaccinated were at higher risk for COVID-19. The aerodynamic experiment verified the possibility of aerosol transmission within the same living area.
Conclusion
COVID-19 transmission at army training centers should be minimized through quarantine and post-admission testing during the latency period as part of integrated measures that include facility ventilation, vaccination, indoor mask-wearing, and social distancing.

Citations

Citations to this article as recorded by  
  • COVID-19 outbreak in a religious village community in Republic of Korea and risk factors for transmission
    Jiae Shim, Eunju Lee, Eunyoung Kim, Yeonhwa Choi, Giseok Kang, Bryan Inho Kim
    Osong Public Health and Research Perspectives.2023; 14(2): 110.     CrossRef
Brief Report
Genomic Surveillance of SARS-CoV-2: Distribution of Clades in the Republic of Korea in 2020
Ae Kyung Park, Il-Hwan Kim, Junyoung Kim, Jeong-Min Kim, Heui Man Kim, Chae young Lee, Myung-Guk Han, Gi-Eun Rhie, Donghyok Kwon, Jeong-Gu Nam, Young-Joon Park, Jin Gwack, Nam-Joo Lee, SangHee Woo, Jin Sun No, Jaehee Lee, Jeemin Ha, JeeEun Rhee, Cheon-Kwon Yoo, Eun-Jin Kim
Osong Public Health Res Perspect. 2021;12(1):37-43.   Published online February 23, 2021
DOI: https://doi.org/10.24171/j.phrp.2021.12.1.06
  • 6,186 View
  • 202 Download
  • 17 Citations
AbstractAbstract PDF

Since a novel beta-coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019, there has been a rapid global spread of the virus. Genomic surveillance was conducted on samples isolated from infected individuals to monitor the spread of genetic variants of SARS-CoV-2 in Korea. The Korea Disease Control and Prevention Agency performed whole genome sequencing of SARS-CoV-2 in Korea for 1 year (January 2020 to January 2021). A total of 2,488 SARS-CoV-2 cases were sequenced (including 648 cases from abroad). Initially, the prevalent clades of SARS-CoV-2 were the S and V clades, however, by March 2020, GH clade was the most dominant. Only international travelers were identified as having G or GR clades, and since the first variant 501Y.V1 was identified (from a traveler from the United Kingdom on December 22nd, 2020), a total of 27 variants of 501Y.V1, 501Y.V2, and 484K.V2 have been classified (as of January 25th, 2021). The results in this study indicated that quarantining of travelers entering Korea successfully prevented dissemination of the SARS-CoV-2 variants in Korea.

Citations

Citations to this article as recorded by  
  • Rapid Emergence of the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Korea
    Ae Kyung Park, Il-Hwan Kim, Chae Young Lee, Jeong-Ah Kim, Hyeokjin Lee, Heui Man Kim, Nam-Joo Lee, SangHee Woo, Jaehee Lee, JeeEun Rhee, Cheon-Kwon Yoo, Eun-Jin Kim
    Annals of Laboratory Medicine.2023; 43(2): 211.     CrossRef
  • A Seroprevalence Study on Residents in a Senior Care Facility with Breakthrough SARS-CoV-2 Omicron Infection
    Heui Man Kim, Eun Ju Lee, Sang Won O, Yong Jun Choi, Hyeokjin Lee, Sae Jin Oh, Jeong-Min Kim, Ae Kyung Park, Jeong-Ah Kim, Chae young Lee, Jong Mu Kim, Hanul Park, Young Joon Park, Jeong-Hee Yu, Eun-Young Kim, Hwa-Pyeong Ko, Eun-Jin Kim
    Viral Immunology.2023; 36(3): 203.     CrossRef
  • Genomic evidence of SARS‐CoV‐2 reinfection in the Republic of Korea
    Ae Kyung Park, Jee Eun Rhee, Il‐Hwan Kim, Heui Man Kim, Hyeokjin Lee, Jeong‐Ah Kim, Chae Young Lee, Nam‐Joo Lee, SangHee Woo, Jaehee Lee, Jin Sun No, Gi‐Eun Rhie, Seong Jin Wang, Sang‐Eun Lee, Young Joon Park, Gemma Park, Jung Yeon Kim, Jin Gwack, Cheon‐K
    Journal of Medical Virology.2022; 94(4): 1717.     CrossRef
  • SARS-CoV-2 B.1.619 and B.1.620 Lineages, South Korea, 2021
    Ae Kyung Park, Il-Hwan Kim, Heui Man Kim, Hyeokjin Lee, Nam-Joo Lee, Jeong-Ah Kim, SangHee Woo, Chae young Lee, Jaehee Lee, Sae Jin Oh, JeeEun Rhee, Cheon-Kwon Yoo, Eun-Jin Kim
    Emerging Infectious Diseases.2022; 28(2): 415.     CrossRef
  • Humoral and Cellular Responses to COVID-19 Vaccines in SARS-CoV-2 Infection-Naïve and -Recovered Korean Individuals
    Ji-Young Hwang, Yunhwa Kim, Kyung-Min Lee, Eun-Jeong Jang, Chang-Hoon Woo, Chang-Ui Hong, Seok-Tae Choi, Sivilay Xayaheuang, Jong-Geol Jang, June-Hong Ahn, Hosun Park
    Vaccines.2022; 10(2): 332.     CrossRef
  • Increase in Viral Load in Patients With SARS-CoV-2 Delta Variant Infection in the Republic of Korea
    Jeong-Min Kim, Jee Eun Rhee, Myeongsu Yoo, Heui Man Kim, Nam-Joo Lee, Sang Hee Woo, Hye-Jun Jo, Donghyok Kwon, Sangwon Lee, Cheon Kwon Yoo, Eun-Jin Kim
    Frontiers in Microbiology.2022;[Epub]     CrossRef
  • Molecular Dynamics Studies on the Structural Stability Prediction of SARS-CoV-2 Variants Including Multiple Mutants
    Kwang-Eun Choi, Jeong-Min Kim, Jee Eun Rhee, Ae Kyung Park, Eun-Jin Kim, Cheon Kwon Yoo, Nam Sook Kang
    International Journal of Molecular Sciences.2022; 23(9): 4956.     CrossRef
  • SARS-CoV-2 shedding dynamics and transmission in immunosuppressed patients
    Jee-Soo Lee, Ki Wook Yun, Hyeonju Jeong, Boram Kim, Man Jin Kim, Jae Hyeon Park, Ho Seob Shin, Hyeon Sae Oh, Hobin Sung, Myung Gi Song, Sung Im Cho, So Yeon Kim, Chang Kyung Kang, Pyoeng Gyun Choe, Wan Beom Park, Nam Joong Kim, Myoung-Don Oh, Eun Hwa Choi
    Virulence.2022; 13(1): 1242.     CrossRef
  • Immunological and Pathological Peculiarity of Severe Acute Respiratory Syndrome Coronavirus 2 Beta Variant
    Sunhee Lee, Gun Young Yoon, Su Jin Lee, Young-Chan Kwon, Hyun Woo Moon, Yu-Jin Kim, Haesoo Kim, Wooseong Lee, Gi Uk Jeong, Chonsaeng Kim, Kyun-Do Kim, Seong-Jun Kim, Dae-Gyun Ahn, Miguel Angel Martinez
    Microbiology Spectrum.2022;[Epub]     CrossRef
  • Clinical scoring system to predict viable viral shedding in patients with COVID-19
    Sung Woon Kang, Heedo Park, Ji Yeun Kim, Sunghee Park, So Yun Lim, Sohyun Lee, Joon-Yong Bae, Jeonghun Kim, Seongman Bae, Jiwon Jung, Min Jae Kim, Yong Pil Chong, Sang-Oh Lee, Sang-Ho Choi, Yang Soo Kim, Sung-Cheol Yun, Man-Seong Park, Sung-Han Kim
    Journal of Clinical Virology.2022; 157: 105319.     CrossRef
  • Model-informed COVID-19 exit strategy with projections of SARS-CoV-2 infections generated by variants in the Republic of Korea
    Sung-mok Jung, Kyungmin Huh, Munkhzul Radnaabaatar, Jaehun Jung
    BMC Public Health.2022;[Epub]     CrossRef
  • Comparative analysis of mutational hotspots in the spike protein of SARS-CoV-2 isolates from different geographic origins
    Sanghoo Lee, Mi-Kyeong Lee, Hyeongkyun Na, Jinwoo Ahn, Gayeon Hong, Youngkee Lee, Jimyeong Park, Yejin Kim, Yun-Tae Kim, Chang-Ki Kim, Hwan-Sub Lim, Kyoung-Ryul Lee
    Gene Reports.2021; 23: 101100.     CrossRef
  • Review of Current COVID-19 Diagnostics and Opportunities for Further Development
    Yan Mardian, Herman Kosasih, Muhammad Karyana, Aaron Neal, Chuen-Yen Lau
    Frontiers in Medicine.2021;[Epub]     CrossRef
  • Locally harvested Covid-19 convalescent plasma could probably help combat the geographically determined SARS-CoV-2 viral variants
    Manish Raturi, Anuradha Kusum, Mansi Kala, Garima Mittal, Anita Sharma, Naveen Bansal
    Transfusion Clinique et Biologique.2021; 28(3): 300.     CrossRef
  • Molecular Dynamics Studies on the Structural Characteristics for the Stability Prediction of SARS-CoV-2
    Kwang-Eun Choi, Jeong-Min Kim, JeeEun Rhee, Ae Kyung Park, Eun-Jin Kim, Nam Sook Kang
    International Journal of Molecular Sciences.2021; 22(16): 8714.     CrossRef
  • Management following the first confirmed case of SARS-CoV-2 in a domestic cat associated with a massive outbreak in South Korea
    Taewon Han, Boyeong Ryu, Suyeon Lee, Yugyeong Song, Yoongje Jeong, Ilhwan Kim, Jeongmin Kim, Eunjin Kim, Wonjun Lee, Hyunju Lee, Haekyoung Hwang
    One Health.2021; 13: 100328.     CrossRef
  • Genomic epidemiology reveals the reduction of the introduction and spread of SARS-CoV-2 after implementing control strategies in Republic of Korea, 2020
    Jung-Hoon Kwon, Jeong-Min Kim, Dong-hun Lee, Ae Kyung Park, Il-Hwan Kim, Da-Won Kim, Ji-Yun Kim, Noori Lim, Kyeong-Yeon Cho, Heui Man Kim, Nam-Joo Lee, SangHee Woo, Chae Young Lee, Jin Sun No, Junyoung Kim, JeeEun Rhee, Myung-Guk Han, Gi-Eun Rhie, Cheon K
    Virus Evolution.2021;[Epub]     CrossRef
Original Article
Evaluation of the Effectiveness of Pandemic Influenza A(H1N1) 2009 Vaccine Based on an Outbreak Investigation During the 2010–2011 Season in Korean Military Camps
Kyo-Hyun Kim, Yoon Gu Choi, Hyun-Bae Yoon, Jung-Woo Lee, Hyun-Wook Kim, Chaeshin Chu, Young-Joon Park
Osong Public Health Res Perspect. 2013;4(4):209-214.   Published online August 31, 2013
DOI: https://doi.org/10.1016/j.phrp.2013.07.002
  • 2,261 View
  • 16 Download
  • 2 Citations
AbstractAbstract PDF
Objectives
In December 2010, there was an outbreak of acute febrile respiratory disease in many Korean military camps that were not geographically related. A laboratory analysis confirmed a number of these cases to be infected by the pandemic influenza A(H1N1) 2009 (H1N1pdm09) virus. Because mass vaccination against H1N1pdm09 was implemented at the infected military camps eleven months ago, the outbreak areas in which both vaccinated and nonvaccinated individuals were well mixed, gave us an opportunity to evaluate the effectiveness of H1N1pdm09 vaccine through a retrospective cohort study design.
Methods
A self-administered questionnaire was distributed to the three military camps in which the outbreak occurred for case detection, determination of vaccination status, and characterization of other risk factors. The overall response rate was 86.8% (395/455). Case was defined as fever (≥38 °C) with cough or sore throat, influenza-like illness (ILI), and vaccination status verified by vaccination registry. Crude vaccine effectiveness (VE) was calculated as “1 − attack rate in vaccinated individuals/attack rate in nonvaccinated individuals”, and adjusted VE was calculated as “1 – odds ratio” using logistic regression adjusted for potential confounding factor. A number of ILI definitions were used to test the robustness of the result.
Results
The attack rate of ILI was 12.8% in register-verified vaccinated individuals and 24.0% in nonvaccinated individuals. The crude VE was thus calculated to be 46.8% [95% confidence interval (CI): 14.5–66.9]. The adjusted VE rate was 46.8% (95% CI: –9.4 to 74.1). Various combinations of ILI symptoms also showed similar VE rates.
Conclusion
We evaluated the effectiveness of H1N1pdm09 vaccine in the 2010–2011 season in an outbreak setting. Although the result was not sensitive to any analytical method used and ILI case definition, the magnitude of effectiveness was lower than estimated in the 2009–2010 season.

Citations

Citations to this article as recorded by  
  • Assessment of Intensive Vaccination and Antiviral Treatment in 2009 Influenza Pandemic in Korea
    Chaeshin Chu, Sunmi Lee
    Osong Public Health and Research Perspectives.2015; 6(1): 47.     CrossRef
  • Was the Mass Vaccination Effective During the Influenza Pandemic 2009–2010 in Korea?
    Hae-Wol Cho, Chaeshin Chu
    Osong Public Health and Research Perspectives.2013; 4(4): 177.     CrossRef
Brief Report
Revision of the National Action Plan in Response to Poliovirus Importation in Korea
Young-Joon Park, Joon-Woo Kim, Yoon Hyung Kwon, Geun-Ryang Bae, Duk-Hyoung Lee
Osong Public Health Res Perspect. 2013;4(2):117-121.   Published online April 30, 2013
DOI: https://doi.org/10.1016/j.phrp.2013.03.008
  • 2,142 View
  • 13 Download
  • 2 Citations
AbstractAbstract PDF
The polio outbreak in China in 2011 makes it necessary to revise the 2010 polio National Action Plan (NAP) in Korea. The revised plan was provided after evaluation of the 2010 NAP, literature reviews, and expert advice. It was discussed and confirmed by the Polio National Certificate Committee (NCC).The revised NAP (2012 NAP) has structured the action to take by patient phase and the role of each institution. It also provides the specified classification and management actions on the contacts. It includes a new recommendation of onetime additional immunization for the contacts regardless of the immunization history. The 2012 NAP could provide an effective countermeasure if there are imported poliomyelitis patients in Korea.

Citations

Citations to this article as recorded by  
  • Enterovirus Surveillance (EVSurv) in Germany
    Kathrin Keeren, Sindy Böttcher, Sabine Diedrich
    Microorganisms.2021; 9(10): 2005.     CrossRef
  • Fires in the Neighborhood
    Hae-Wol Cho, Chaeshin Chu
    Osong Public Health and Research Perspectives.2013; 4(2): 67.     CrossRef
Original Article
Factors Related to Completed Status and Seropositivity of Hepatitis A Immunization Among Children Aged 1–3 Years and 6–8 Years in South Korea
Jee-Young Hong, Mo Ran Ki, Hye-Jung Hwang, Delacroix Sinny, Young-Joon Park, Geun-Ryang Bae, Moo-Sik Lee
Osong Public Health Res Perspect. 2013;4(2):93-98.   Published online April 30, 2013
DOI: https://doi.org/10.1016/j.phrp.2013.02.004
  • 2,795 View
  • 11 Download
  • 2 Citations
AbstractAbstract PDF
This study was designed to identify factors associated with hepatitis A immunization status and seropositivity in Korean children. In-person interviews, reviewing their vaccination cards and testing hepatitis A antibody were conducted with 389 children aged 1–3 years and 544 children aged 6–8 years. In all age groups, earlier birth order was the only significant factor in children receiving either single or both doses of the vaccination. And completion of the second dose of vaccination was a prerequisite for increased seropositivity. Additionally, household income had a positive impact on seropositivity only in children aged 6–8 years. Our findings suggest that presence of an economic barrier is the underlying cause of the decreased hepatitis A vaccination services in Korea. Therefore, hepatitis A vaccine should be included in the essential National Immunization Program.

Citations

Citations to this article as recorded by  
  • Vaccine Uptake to Prevent Meningitis and Encephalitis in Shanghai, China
    Hairenguli Maimaiti, Jia Lu, Xiang Guo, Lu Zhou, Linjie Hu, Yihan Lu
    Vaccines.2022; 10(12): 2054.     CrossRef
  • Changing sero-epidemiology of hepatitis A in Asia Pacific countries: A systematic review
    Marissa Gripenberg, Naveena Aloysia D’Cor, Maïna L’Azou, Grenville Marsh, Sophie Druelles, Joshua Nealon
    International Journal of Infectious Diseases.2018; 68: 13.     CrossRef

PHRP : Osong Public Health and Research Perspectives